Bausch Health (NYSE/TSX: BHC) Appoints New Executives to Strengthen Leadership Team

2 min read | July 22, 2024 02:38 AM EDT | By Team Kalkine Media

Google News:

Bausch Health (NYSE/TSX: BHC) Appoints New Executives to Strengthen Leadership Team — Image source: © Andreyyalansky19 | Megapixl.com

Recent News

Why Is Canadian Natural Resources (TSX:CNQ) Leading S&P/TSX 60 Energy...

Why Is Canad Natural Resources (TSX:CNQ) Boosting S&P/TSX 60 Energy?

Why Is Canadian Natural Resources (TSX:CNQ) Steady in TSX 60?

Why Is Brookfield (TSX:BN) Helping Stabilize the S&P/TSX 60?

Make Kalkine Media
My Trusted Source

Bausch Health Companies Inc. (NYSE/TSX: BHC) has announced the appointment of two seasoned executives to its Executive Leadership Team (ELT), effective in the coming months.

Jean-Jacques Charhon Appointed CFO

Jean-Jacques Charhon, known as "JJ," will join Bausch Health as Chief Financial Officer on August 19, 2024. Charhon brings over 25 years of extensive financial leadership experience from his roles at General Electric, Hewlett Packard, Novartis, and Purdue Pharma. Most recently, he served as Executive Vice President and Chief Financial Officer at Signant Health, where he was responsible for financial planning, analysis, accounting, controllership, treasury, tax, and procurement.

Charhon’s expertise spans both public and private sectors, and he is recognized for his ability to drive business enablement through strategic financial management. He holds a master’s degree in business administration from the Solvay School of Management in Brussels, Belgium. Following his appointment, John Barresi, the current Interim CFO, will return to his position as Senior Vice President and Controller.

Aimee Lenar Joins as Executive Vice President, US Pharma

Aimee Lenar has been appointed as Executive Vice President, US Pharma, effective July 15, 2024. In this role, she will lead Salix Pharmaceuticals, Bausch Health’s gastroenterology division, as well as oversee Neurology, Generics, Market Access, and Commercial Operations. Lenar joins Bausch Health from Galderma, where she was Head of US Prescription Medicine, managing sales, marketing, market access, and business analytics.

Lenar’s career includes significant positions at AbbVie and Allergan, where she demonstrated her leadership in sales and marketing. She has a proven track record in driving growth and managing extensive product portfolios. Lenar holds a master’s degree in public health from Emory University.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company dedicated to improving health outcomes through its extensive portfolio and innovative solutions. The recent additions to the leadership team are expected to enhance the company’s strategic execution and operational effectiveness, driving forward its mission to deliver better health outcomes globally.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.